(marketscreener.com) Ownership Submission FORM 3/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16 of the Securities Exchange Act of 1934 or Section 30 of the...https://www.marketscreener.com/quote/stock/FORMA-THERAPEUTICS-HOLDIN-108665623/news/Forma-Therapeutics-Amendment-to-Initial-Statement-of-Beneficial-Ownership-Form-3-A-41810415/?utm_medium=RSS&utm_content=20220919
Forma Therapeutics is a Massachusetts-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of rare hematologic diseases.